Last update 16 May 2025

Bucillamine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bucillamine (JP17/INN), DE-019, REV-002
+ [6]
Target-
Action
modulators
Mechanism
Immunomodulators
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (30 Jun 1987),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC7H13NO3S2
InChIKeyVUAFHZCUKUDDBC-BYPYZUCNSA-N
CAS Registry65002-17-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Rheumatoid Arthritis
Japan
30 Jun 1987
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
United States
27 Nov 2020
COVID-19Phase 3
Puerto Rico
27 Nov 2020
CystinuriaPhase 2
United States
01 May 2017
Primary goutPhase 2
United States
01 Apr 2015
Reperfusion InjuryPhase 2--
Hepatitis, AutoimmuneIND Application
United States
19 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
713
-
Negative
06 Jul 2023
placebo
ceuktwbwjb(miffcesord) = ffazsvkwum okfzhqwjwh (azlkokcsru )
Not Met
Not Applicable
Rheumatoid Arthritis
HLA-DRB1*08:02 | DQB1*04:02
485
(HLA-DRB1*08:02)
rbfwhdwynb(bvczeowftj): P-Value = 1.09X10-6
Positive
25 Oct 2013
(DQB1*04:02)
Not Applicable
835
xvutafhpja(qdholppwpn) = pzkcrmrnhr qegulnjhxv (ofzgqzoger )
-
16 Jun 2010
Not Applicable
8
mepjnagdne(elpubhdkbr) = ewqokufulu mlmefbajob (etpwgjjuxk, 2.33)
-
08 Jun 2005
mepjnagdne(elpubhdkbr) = icywneiywx mlmefbajob (etpwgjjuxk, 4.80)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free